Lycoris, whose various species are known by common names such as spider lily, surprise lily, naked lady and others, are that ...

Spider-Man is one of the few Marvel heroes with a supporting cast and rogues gallery wide enough to support an entire cinematic universe. Or so execs at Sony thought when they launched their ...

Spider-Man 4 is officially happening and, in a twist no one saw coming, Stranger Things star Sadie Sink is reportedly joining Tom Holland. While the trilogy wrapped up everything nicely, it also ...

Levi opted for a more casual look, sporting a patterned, maroon button-down, tan chinos and a black bomber jacket on the red carpet. Meanwhile, Matthew and Alves both wore black suits, with the ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

Petechiae are tiny red or purple dots that don't turn white when you press on them. They can be caused by infections, certain medications, and vitamin deficiencies. They can also be a symptom of low ...

It's very much my pleasure to welcome members of Lilly's leadership team to be here with us in Miami, and thank you for making the trip. So, to my right is Lucas Montarce who is the company's CFO ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

Spider-Man 4 is swinging into cinemas in July 2026, but there has been a slight delay to its original release date. Before filming gets under way on the new movie this summer, Sony has confirmed ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.